TYTL Closes Strategic Investment from Strobe and Fifth Era; Launches Blockchain-Based Fractional Real Estate Equity Platform with Beeline and Anchorage Digital Bank Partnerships

TYTL has launched a debt-free alternative for homeowners seeking to access their home equity. Rather than offering HELOCs, reverse mortgages, or home equity investment (HEI) products, TYTL acquires ...

TechTarget (TTGT) Q4 2025 Earnings Call Transcript

Adjusted EBITDA -- $87.3 million for the year, reflecting 10% growth against $78.8 million in 2024 and exceeding management's guidance of $85 million. Adjusted EBITDA Margin -- 17.9% for the year, ...

MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism

Detailed price information for Mbx Biosciences Inc (MBX-Q) from The Globe and Mail including charting and trades.
The Manila Times

Pacira BioSciences Reaffirms Commitment to Shareholder Value Creation

Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today confirmed that DOMA Perpetual ...

Fusion Fuel Highlights Anticipated Royalty Exposure to Jaguar Uranium 2026 Exploration Program at Laguna Salada, Berlin and Huemul Uranium Projects

Royal Uranium Holds 2.0% NSR Royalty on Laguna Salada Project’s Guanaco Concession and 1.0% NSR Royalties on Berlin and Huemul Projects as Jaguar ...

Informa TechTarget Reports Fourth Quarter and Full Year 2025 Results

TechTarget, Inc. (Nasdaq: TTGT), ("Informa TechTarget" or the "Company"), a leading growth accelerator for the B2B Technology sector, today reports financial results for the fourth quarter and ...
The Globe and Mail

CORRECTING & REPLACING -- MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism

In the fourth paragraph, we are replacing milligrams with micrograms. The corrected press release follows. CARMEL, Ind., March 09, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a ...
The Manila Times

CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering

CRISPR Therapeutics AG (Nasdaq: CRSP) (the 'Company”) today announced the pricing of $550 million aggregate principal amount of its convertible senior notes due 2031 (the 'notes”) in a private ...

Katapult Reports Fourth Quarter and Full Year 2025 Results

Delivers 13th Consecutive Quarter of Gross Originations Growth Pending Merger Transaction with The Aaron’s Company and CCF Holdings LLC Expected to Create a Premier Omnichannel Platform for Nonprime ...
Taiwan News

24/7 Market News: Kraig Labs the Bootstrapped Unicorn in the Making

DENVER, March 11, 2026 (GLOBE NEWSWIRE)-- 247marketnews.com-- In technology and biotechnology, “unicorn” status is typically reserved for private companies valued at $1 billion or more; often backed ...

Algo Grande Copper Corp.: Algo Grande Identifies Additional Skarn Mineralization 3km South of Cerro Grande, With Samples Above 3% Copper and Confirms Copper in Multiple Targets ...

VANCOUVER, BC / ACCESS Newswire / March 11, 2026 / Algo Grande Copper Corp. ("Algo Grande") (TSXV:ALGR)(OTC:KNDYF)(FRA:KM00) is pleased to provide an exploration update on its 100%-owned Adelita Proje ...
Finanznachrichten

CRISPR Therapeutics AG: CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering

ZUG, Switzerland and BOSTON, March 11, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics AG (Nasdaq: CRSP) (the "Company") today announced the pricing of $550 million aggregate principal amount of its ...